nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—MAPK1—Downstream signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.00313	0.00321	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.00306	0.00314	CbGpPWpGaD
Isoprenaline—PIK3R1—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.00298	0.00305	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—CARD9—ankylosing spondylitis	0.00292	0.00299	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—CARD9—ankylosing spondylitis	0.00287	0.00295	CbGpPWpGaD
Isoprenaline—PIK3R2—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.00287	0.00294	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—ANTXR2—ankylosing spondylitis	0.00284	0.00291	CbGpPWpGaD
Isoprenaline—PIK3R2—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	0.00284	0.00291	CbGpPWpGaD
Isoprenaline—MAPK1—TCR Signaling Pathway—IL1A—ankylosing spondylitis	0.00279	0.00286	CbGpPWpGaD
Isoprenaline—PIK3R2—DAP12 interactions—HLA-B—ankylosing spondylitis	0.00279	0.00286	CbGpPWpGaD
Isoprenaline—ADRBK1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.00275	0.00282	CbGpPWpGaD
Isoprenaline—ADRB1—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00273	0.0028	CbGpPWpGaD
Isoprenaline—PIK3R1—B Cell Activation—CD79A—ankylosing spondylitis	0.0027	0.00277	CbGpPWpGaD
Isoprenaline—MAPK1—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.00268	0.00275	CbGpPWpGaD
Isoprenaline—ADRB2—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00267	0.00274	CbGpPWpGaD
Isoprenaline—PIK3R2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.00267	0.00274	CbGpPWpGaD
Isoprenaline—PIK3R1—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	0.00265	0.00272	CbGpPWpGaD
Isoprenaline—ADRBK1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.00263	0.0027	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—KIR3DL1—ankylosing spondylitis	0.00262	0.00269	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 interactions—HLA-C—ankylosing spondylitis	0.0026	0.00266	CbGpPWpGaD
Isoprenaline—PIK3R3—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.00256	0.00263	CbGpPWpGaD
Isoprenaline—ADRB3—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00256	0.00263	CbGpPWpGaD
Isoprenaline—PIK3R3—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.00254	0.00261	CbGpPWpGaD
Isoprenaline—PIK3R1—Angiopoietin receptor Tie2-mediated signaling—TNF—ankylosing spondylitis	0.00248	0.00255	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.00248	0.00255	CbGpPWpGaD
Isoprenaline—MAPK1—Senescence-Associated Secretory Phenotype (SASP)—IL1A—ankylosing spondylitis	0.00247	0.00253	CbGpPWpGaD
Isoprenaline—MAPK1—Senescence and Autophagy in Cancer—IL1A—ankylosing spondylitis	0.00247	0.00253	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL1R2—ankylosing spondylitis	0.00246	0.00252	CbGpPWpGaD
Isoprenaline—PIK3R3—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	0.00242	0.00249	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by Interleukins—IL1A—ankylosing spondylitis	0.00241	0.00247	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—CARD9—ankylosing spondylitis	0.00236	0.00243	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—ERAP1—ankylosing spondylitis	0.00233	0.00239	CbGpPWpGaD
Isoprenaline—PIK3R1—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.00232	0.00238	CbGpPWpGaD
Isoprenaline—PIK3R1—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	0.0023	0.00236	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—HLA-C—ankylosing spondylitis	0.0023	0.00236	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—ANTXR2—ankylosing spondylitis	0.00226	0.00232	CbGpPWpGaD
Isoprenaline—PIK3R1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.00226	0.00232	CbGpPWpGaD
Isoprenaline—MAPK1—Spinal Cord Injury—IL1A—ankylosing spondylitis	0.00225	0.0023	CbGpPWpGaD
Isoprenaline—PIK3R3—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	0.00225	0.0023	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—ANTXR2—ankylosing spondylitis	0.00223	0.00229	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.00221	0.00226	CbGpPWpGaD
Isoprenaline—MAPK1—Corticotropin-releasing hormone—TLR4—ankylosing spondylitis	0.0022	0.00225	CbGpPWpGaD
Isoprenaline—ADRB3—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00219	0.00225	CbGpPWpGaD
Isoprenaline—PIK3R3—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.00218	0.00223	CbGpPWpGaD
Isoprenaline—PIK3R1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.00216	0.00222	CbGpPWpGaD
Isoprenaline—MAPK1—MyD88:Mal cascade initiated on plasma membrane—TLR4—ankylosing spondylitis	0.00216	0.00222	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—CARD9—ankylosing spondylitis	0.00213	0.00219	CbGpPWpGaD
Isoprenaline—MAPK1—MyD88-independent cascade—TLR4—ankylosing spondylitis	0.00207	0.00213	CbGpPWpGaD
Isoprenaline—PIK3R2—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.00204	0.0021	CbGpPWpGaD
Isoprenaline—PIK3R2—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.00203	0.00208	CbGpPWpGaD
Isoprenaline—MAPK1—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.00202	0.00208	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL1R2—ankylosing spondylitis	0.00196	0.00201	CbGpPWpGaD
Isoprenaline—MAPK1—TWEAK Signaling Pathway—TNF—ankylosing spondylitis	0.00194	0.00199	CbGpPWpGaD
Isoprenaline—PIK3R2—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	0.00193	0.00198	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL1R2—ankylosing spondylitis	0.00193	0.00198	CbGpPWpGaD
Isoprenaline—MAPK1—Activated TLR4 signalling—TLR4—ankylosing spondylitis	0.00186	0.00191	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—ERAP1—ankylosing spondylitis	0.00186	0.00191	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—ANTXR2—ankylosing spondylitis	0.00183	0.00188	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—HLA-C—ankylosing spondylitis	0.00183	0.00188	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—ERAP1—ankylosing spondylitis	0.00183	0.00188	CbGpPWpGaD
Isoprenaline—MAPK1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.00181	0.00185	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—HLA-C—ankylosing spondylitis	0.0018	0.00185	CbGpPWpGaD
Isoprenaline—MAPK1—Spinal Cord Injury—TLR4—ankylosing spondylitis	0.0018	0.00185	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	0.0018	0.00185	CbGpPWpGaD
Isoprenaline—PIK3R2—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	0.00179	0.00184	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—KIR3DL1—ankylosing spondylitis	0.00178	0.00183	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.00176	0.00181	CbGpPWpGaD
Isoprenaline—MAPK1—Toll Like Receptor 4 (TLR4) Cascade—TLR4—ankylosing spondylitis	0.00175	0.0018	CbGpPWpGaD
Isoprenaline—MAPK1—Ceramide signaling pathway—TNF—ankylosing spondylitis	0.00175	0.00179	CbGpPWpGaD
Isoprenaline—PIK3R2—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.00173	0.00178	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CARD9—ankylosing spondylitis	0.0017	0.00174	CbGpPWpGaD
Isoprenaline—PIK3R3—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	0.0017	0.00174	CbGpPWpGaD
Isoprenaline—MAPK1—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.00169	0.00174	CbGpPWpGaD
Isoprenaline—MAPK1—Angiopoietin receptor Tie2-mediated signaling—TNF—ankylosing spondylitis	0.00169	0.00173	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—CD79A—ankylosing spondylitis	0.00168	0.00173	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CARD9—ankylosing spondylitis	0.00167	0.00172	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—B3GNT2—ankylosing spondylitis	0.00167	0.00172	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00167	0.00171	CbGpPWpGaD
Isoprenaline—PIK3R1—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.00165	0.0017	CbGpPWpGaD
Isoprenaline—PIK3R1—Apoptosis—TNF—ankylosing spondylitis	0.00164	0.00168	CbGpPWpGaD
Isoprenaline—PIK3R1—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.00164	0.00168	CbGpPWpGaD
Isoprenaline—MAPK1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—ankylosing spondylitis	0.00161	0.00165	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—CARD9—ankylosing spondylitis	0.00161	0.00165	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL1R2—ankylosing spondylitis	0.00159	0.00163	CbGpPWpGaD
Isoprenaline—MAPK1—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.00158	0.00162	CbGpPWpGaD
Isoprenaline—PIK3R1—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	0.00157	0.00161	CbGpPWpGaD
Isoprenaline—MAPK1—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.00157	0.00161	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	0.00156	0.0016	CbGpPWpGaD
Isoprenaline—MAPK1—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.00156	0.0016	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular Senescence—IL1A—ankylosing spondylitis	0.00156	0.0016	CbGpPWpGaD
Isoprenaline—MAPK1—DAP12 interactions—HLA-B—ankylosing spondylitis	0.00154	0.00158	CbGpPWpGaD
Isoprenaline—ADRB1—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00152	0.00156	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—ERAP1—ankylosing spondylitis	0.00151	0.00154	CbGpPWpGaD
Isoprenaline—PIK3R3—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.0015	0.00154	CbGpPWpGaD
Isoprenaline—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00149	0.00153	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—HLA-C—ankylosing spondylitis	0.00148	0.00152	CbGpPWpGaD
Isoprenaline—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.00147	0.00151	CbGpPWpGaD
Isoprenaline—PIK3R1—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	0.00145	0.00149	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.00143	0.00146	CbGpPWpGaD
Isoprenaline—PIK3R1—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.0014	0.00144	CbGpPWpGaD
Isoprenaline—PIK3R3—Metabolism—B3GNT2—ankylosing spondylitis	0.0014	0.00144	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CARD9—ankylosing spondylitis	0.00138	0.00141	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.00137	0.00141	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00136	0.0014	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—HLA-B—ankylosing spondylitis	0.00136	0.00139	CbGpPWpGaD
Isoprenaline—PIK3R2—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	0.00135	0.00139	CbGpPWpGaD
Isoprenaline—MAPK1—Downstream signaling in naïve CD8+ T cells—TNF—ankylosing spondylitis	0.00135	0.00139	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—CD79A—ankylosing spondylitis	0.00134	0.00138	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—HLA-C—ankylosing spondylitis	0.00134	0.00137	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—B3GNT2—ankylosing spondylitis	0.00133	0.00137	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—B3GNT2—ankylosing spondylitis	0.00131	0.00135	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.0013	0.00134	CbGpPWpGaD
Isoprenaline—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.0013	0.00134	CbGpPWpGaD
Isoprenaline—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00127	0.00131	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—ANTXR2—ankylosing spondylitis	0.00125	0.00128	CbGpPWpGaD
Isoprenaline—PIK3R3—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.00121	0.00124	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—CRP—ankylosing spondylitis	0.0012	0.00123	CbGpPWpGaD
Isoprenaline—PIK3R2—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00119	0.00123	CbGpPWpGaD
Isoprenaline—MAPK1—Cellular responses to stress—IL1A—ankylosing spondylitis	0.00118	0.00121	CbGpPWpGaD
Isoprenaline—ADRBK1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00118	0.00121	CbGpPWpGaD
Isoprenaline—MAPK1—Alzheimers Disease—TNF—ankylosing spondylitis	0.00117	0.0012	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL1RN—ankylosing spondylitis	0.00116	0.00119	CbGpPWpGaD
Isoprenaline—PIK3R3—Innate Immune System—TLR4—ankylosing spondylitis	0.00115	0.00118	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.00112	0.00115	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—B3GNT2—ankylosing spondylitis	0.00112	0.00115	CbGpPWpGaD
Isoprenaline—MAPK1—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.00112	0.00114	CbGpPWpGaD
Isoprenaline—PIK3R1—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	0.0011	0.00113	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.00109	0.00112	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—CD79A—ankylosing spondylitis	0.00109	0.00112	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00108	0.00111	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—HLA-B—ankylosing spondylitis	0.00108	0.00111	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—B3GNT2—ankylosing spondylitis	0.00108	0.00111	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1R2—ankylosing spondylitis	0.00108	0.00111	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.00107	0.0011	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—HLA-B—ankylosing spondylitis	0.00107	0.00109	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—HLA-C—ankylosing spondylitis	0.00107	0.00109	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	0.00106	0.00109	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—HLA-C—ankylosing spondylitis	0.00105	0.00108	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.00104	0.00107	CbGpPWpGaD
Isoprenaline—MAPK1—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	0.00104	0.00106	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—ERAP1—ankylosing spondylitis	0.00102	0.00105	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—CD79A—ankylosing spondylitis	0.00102	0.00105	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—HLA-C—ankylosing spondylitis	0.00101	0.00104	CbGpPWpGaD
Isoprenaline—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	0.001	0.00103	CbGpPWpGaD
Isoprenaline—CYP1A1—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.001	0.00103	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000992	0.00102	CbGpPWpGaD
Isoprenaline—MAPK1—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	0.000986	0.00101	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00097	0.000996	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000969	0.000994	CbGpPWpGaD
Isoprenaline—PIK3R1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000968	0.000993	CbGpPWpGaD
Isoprenaline—PIK3R2—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000964	0.000989	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—CRP—ankylosing spondylitis	0.000958	0.000983	CbGpPWpGaD
Isoprenaline—MAPK1—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	0.000955	0.00098	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000944	0.000969	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—CRP—ankylosing spondylitis	0.000943	0.000968	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CARD9—ankylosing spondylitis	0.000936	0.00096	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL1RN—ankylosing spondylitis	0.000927	0.000951	CbGpPWpGaD
Isoprenaline—PIK3R2—Innate Immune System—TLR4—ankylosing spondylitis	0.000918	0.000942	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL1RN—ankylosing spondylitis	0.000913	0.000937	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—B3GNT2—ankylosing spondylitis	0.000905	0.000929	CbGpPWpGaD
Isoprenaline—ADRBK1—Innate Immune System—TLR4—ankylosing spondylitis	0.000904	0.000928	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—CD40LG—ankylosing spondylitis	0.000886	0.000909	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000879	0.000902	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—HLA-B—ankylosing spondylitis	0.000878	0.000901	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—HLA-C—ankylosing spondylitis	0.000864	0.000887	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000858	0.00088	CbGpPWpGaD
Isoprenaline—MAPK1—Spinal Cord Injury—TNF—ankylosing spondylitis	0.00085	0.000872	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—HLA-B—ankylosing spondylitis	0.000843	0.000865	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL1A—ankylosing spondylitis	0.000837	0.000859	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—CD40LG—ankylosing spondylitis	0.000832	0.000854	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CD79A—ankylosing spondylitis	0.000814	0.000835	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000804	0.000825	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CD79A—ankylosing spondylitis	0.000802	0.000822	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—HLA-B—ankylosing spondylitis	0.000792	0.000812	CbGpPWpGaD
Isoprenaline—PIK3R1—Adaptive Immune System—HLA-A—ankylosing spondylitis	0.000781	0.000801	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—CRP—ankylosing spondylitis	0.000776	0.000796	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000772	0.000792	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000761	0.00078	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL1RN—ankylosing spondylitis	0.000751	0.000771	CbGpPWpGaD
Isoprenaline—MAPK1—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	0.000745	0.000765	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—TLR4—ankylosing spondylitis	0.000744	0.000763	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—B3GNT2—ankylosing spondylitis	0.000735	0.000754	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—HLA-A—ankylosing spondylitis	0.000733	0.000753	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—CRP—ankylosing spondylitis	0.0007	0.000718	CbGpPWpGaD
Isoprenaline—Pulmonary oedema—Prednisolone—ankylosing spondylitis	0.000693	0.0272	CcSEcCtD
Isoprenaline—PIK3R3—Disease—HLA-A—ankylosing spondylitis	0.000677	0.000695	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—TLR4—ankylosing spondylitis	0.000671	0.000688	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL1A—ankylosing spondylitis	0.000667	0.000685	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CD40LG—ankylosing spondylitis	0.000663	0.000681	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CD79A—ankylosing spondylitis	0.000659	0.000677	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL1A—ankylosing spondylitis	0.000657	0.000674	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CD40LG—ankylosing spondylitis	0.000653	0.00067	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000641	0.000657	CbGpPWpGaD
Isoprenaline—MAPK1—MAPK Signaling Pathway—TNF—ankylosing spondylitis	0.000641	0.000657	CbGpPWpGaD
Isoprenaline—Pulmonary oedema—Triamcinolone—ankylosing spondylitis	0.000637	0.025	CcSEcCtD
Isoprenaline—Pulmonary oedema—Methylprednisolone—ankylosing spondylitis	0.000636	0.0249	CcSEcCtD
Isoprenaline—ADRBK1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000631	0.000648	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—HLA-B—ankylosing spondylitis	0.000631	0.000647	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000626	0.000642	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—HLA-B—ankylosing spondylitis	0.000621	0.000638	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000611	0.000627	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000597	0.000613	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—HLA-B—ankylosing spondylitis	0.000597	0.000612	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HLA-C—ankylosing spondylitis	0.000588	0.000603	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—HLA-A—ankylosing spondylitis	0.000585	0.0006	CbGpPWpGaD
Isoprenaline—Pulmonary oedema—Betamethasone—ankylosing spondylitis	0.000578	0.0227	CcSEcCtD
Isoprenaline—Pulmonary oedema—Dexamethasone—ankylosing spondylitis	0.000578	0.0227	CcSEcCtD
Isoprenaline—MAPK1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	0.000578	0.000593	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—HLA-A—ankylosing spondylitis	0.000576	0.000591	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MMP3—ankylosing spondylitis	0.000572	0.000587	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000561	0.000575	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—CRP—ankylosing spondylitis	0.000558	0.000572	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—CRP—ankylosing spondylitis	0.000549	0.000564	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000548	0.000563	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL1A—ankylosing spondylitis	0.000541	0.000555	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—HLA-A—ankylosing spondylitis	0.00054	0.000554	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CD40LG—ankylosing spondylitis	0.000537	0.000552	CbGpPWpGaD
Isoprenaline—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.000537	0.0211	CcSEcCtD
Isoprenaline—PIK3R2—Immune System—TLR4—ankylosing spondylitis	0.000535	0.000549	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—HLA-A—ankylosing spondylitis	0.000532	0.000546	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—CRP—ankylosing spondylitis	0.000527	0.000541	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—TLR4—ankylosing spondylitis	0.000527	0.00054	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000519	0.000533	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—HLA-B—ankylosing spondylitis	0.000511	0.000525	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1RN—ankylosing spondylitis	0.00051	0.000524	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000509	0.000522	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000507	0.00052	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—TLR4—ankylosing spondylitis	0.000506	0.000519	CbGpPWpGaD
Isoprenaline—Pulmonary oedema—Prednisone—ankylosing spondylitis	0.000504	0.0197	CcSEcCtD
Isoprenaline—ADRB2—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000498	0.000511	CbGpPWpGaD
Isoprenaline—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.000494	0.0194	CcSEcCtD
Isoprenaline—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.000493	0.0193	CcSEcCtD
Isoprenaline—PIK3R1—Immune System—HLA-A—ankylosing spondylitis	0.000474	0.000486	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MMP3—ankylosing spondylitis	0.000456	0.000468	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CRP—ankylosing spondylitis	0.000452	0.000464	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MMP3—ankylosing spondylitis	0.000449	0.000461	CbGpPWpGaD
Isoprenaline—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.000448	0.0176	CcSEcCtD
Isoprenaline—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.000448	0.0176	CcSEcCtD
Isoprenaline—MAPK1—Immune System—CD79A—ankylosing spondylitis	0.000448	0.00046	CbGpPWpGaD
Isoprenaline—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.000441	0.0173	CcSEcCtD
Isoprenaline—PIK3R1—Disease—HLA-A—ankylosing spondylitis	0.000437	0.000449	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—TLR4—ankylosing spondylitis	0.000433	0.000445	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000425	0.000436	CbGpPWpGaD
Isoprenaline—Pulmonary oedema—Methotrexate—ankylosing spondylitis	0.000421	0.0165	CcSEcCtD
Isoprenaline—Cardiac arrest—Prednisone—ankylosing spondylitis	0.000391	0.0153	CcSEcCtD
Isoprenaline—Sweating—Methylprednisolone—ankylosing spondylitis	0.000383	0.015	CcSEcCtD
Isoprenaline—PIK3R1—Signaling Pathways—MMP3—ankylosing spondylitis	0.00037	0.000379	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1A—ankylosing spondylitis	0.000367	0.000377	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD40LG—ankylosing spondylitis	0.000365	0.000375	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000362	0.000372	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MMP3—ankylosing spondylitis	0.000361	0.00037	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000355	0.000364	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000353	0.000362	CbGpPWpGaD
Isoprenaline—Arrhythmia—Prednisolone—ankylosing spondylitis	0.000349	0.0137	CcSEcCtD
Isoprenaline—MAPK1—Immune System—HLA-B—ankylosing spondylitis	0.000347	0.000357	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—B3GNT2—ankylosing spondylitis	0.000341	0.00035	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HLA-A—ankylosing spondylitis	0.000322	0.00033	CbGpPWpGaD
Isoprenaline—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.000321	0.0126	CcSEcCtD
Isoprenaline—Vision blurred—Prednisolone—ankylosing spondylitis	0.000321	0.0126	CcSEcCtD
Isoprenaline—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00032	0.0126	CcSEcCtD
Isoprenaline—MAPK1—Immune System—CRP—ankylosing spondylitis	0.000307	0.000315	CbGpPWpGaD
Isoprenaline—Vertigo—Prednisolone—ankylosing spondylitis	0.000306	0.012	CcSEcCtD
Isoprenaline—ADRB1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000301	0.000309	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—HLA-A—ankylosing spondylitis	0.000297	0.000305	CbGpPWpGaD
Isoprenaline—Convulsion—Prednisolone—ankylosing spondylitis	0.000295	0.0116	CcSEcCtD
Isoprenaline—MAPK1—Immune System—TLR4—ankylosing spondylitis	0.000294	0.000302	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000294	0.000302	CbGpPWpGaD
Isoprenaline—Hypertension—Prednisolone—ankylosing spondylitis	0.000294	0.0115	CcSEcCtD
Isoprenaline—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000291	0.0114	CcSEcCtD
Isoprenaline—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000291	0.0114	CcSEcCtD
Isoprenaline—Vertigo—Triamcinolone—ankylosing spondylitis	0.000281	0.011	CcSEcCtD
Isoprenaline—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000281	0.011	CcSEcCtD
Isoprenaline—Convulsion—Triamcinolone—ankylosing spondylitis	0.000271	0.0106	CcSEcCtD
Isoprenaline—Tachycardia—Prednisolone—ankylosing spondylitis	0.000271	0.0106	CcSEcCtD
Isoprenaline—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000271	0.0106	CcSEcCtD
Isoprenaline—MAPK1—Developmental Biology—TNF—ankylosing spondylitis	0.00027	0.000277	CbGpPWpGaD
Isoprenaline—Hypertension—Triamcinolone—ankylosing spondylitis	0.00027	0.0106	CcSEcCtD
Isoprenaline—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00027	0.0106	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000269	0.0105	CcSEcCtD
Isoprenaline—Flushing—Prednisone—ankylosing spondylitis	0.000264	0.0103	CcSEcCtD
Isoprenaline—Vertigo—Dexamethasone—ankylosing spondylitis	0.000255	0.01	CcSEcCtD
Isoprenaline—Vertigo—Betamethasone—ankylosing spondylitis	0.000255	0.01	CcSEcCtD
Isoprenaline—Arrhythmia—Prednisone—ankylosing spondylitis	0.000254	0.00995	CcSEcCtD
Isoprenaline—Sweating—Methotrexate—ankylosing spondylitis	0.000254	0.00994	CcSEcCtD
Isoprenaline—Insomnia—Prednisolone—ankylosing spondylitis	0.000251	0.00985	CcSEcCtD
Isoprenaline—MAPK1—Signaling Pathways—MMP3—ankylosing spondylitis	0.000251	0.000258	CbGpPWpGaD
Isoprenaline—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000249	0.00978	CcSEcCtD
Isoprenaline—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000249	0.00976	CcSEcCtD
Isoprenaline—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000247	0.00968	CcSEcCtD
Isoprenaline—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000246	0.00966	CcSEcCtD
Isoprenaline—Convulsion—Betamethasone—ankylosing spondylitis	0.000246	0.00965	CcSEcCtD
Isoprenaline—Convulsion—Dexamethasone—ankylosing spondylitis	0.000246	0.00965	CcSEcCtD
Isoprenaline—Hypertension—Dexamethasone—ankylosing spondylitis	0.000245	0.00962	CcSEcCtD
Isoprenaline—Hypertension—Betamethasone—ankylosing spondylitis	0.000245	0.00962	CcSEcCtD
Isoprenaline—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000238	0.00934	CcSEcCtD
Isoprenaline—Vision blurred—Prednisone—ankylosing spondylitis	0.000233	0.00914	CcSEcCtD
Isoprenaline—Insomnia—Triamcinolone—ankylosing spondylitis	0.000231	0.00906	CcSEcCtD
Isoprenaline—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000231	0.00904	CcSEcCtD
Isoprenaline—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000228	0.00893	CcSEcCtD
Isoprenaline—Tachycardia—Betamethasone—ankylosing spondylitis	0.000226	0.00887	CcSEcCtD
Isoprenaline—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000226	0.00887	CcSEcCtD
Isoprenaline—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000224	0.00879	CcSEcCtD
Isoprenaline—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000224	0.00879	CcSEcCtD
Isoprenaline—Vertigo—Prednisone—ankylosing spondylitis	0.000222	0.00871	CcSEcCtD
Isoprenaline—Hypotension—Dexamethasone—ankylosing spondylitis	0.000217	0.00849	CcSEcCtD
Isoprenaline—Hypotension—Betamethasone—ankylosing spondylitis	0.000217	0.00849	CcSEcCtD
Isoprenaline—Convulsion—Prednisone—ankylosing spondylitis	0.000214	0.0084	CcSEcCtD
Isoprenaline—ADRB1—Signaling Pathways—MMP3—ankylosing spondylitis	0.000214	0.00022	CbGpPWpGaD
Isoprenaline—Hypertension—Prednisone—ankylosing spondylitis	0.000214	0.00837	CcSEcCtD
Isoprenaline—Insomnia—Dexamethasone—ankylosing spondylitis	0.00021	0.00822	CcSEcCtD
Isoprenaline—Insomnia—Betamethasone—ankylosing spondylitis	0.00021	0.00822	CcSEcCtD
Isoprenaline—ADRB2—Signaling Pathways—MMP3—ankylosing spondylitis	0.000209	0.000215	CbGpPWpGaD
Isoprenaline—Tachycardia—Prednisone—ankylosing spondylitis	0.000197	0.00773	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000195	0.00765	CcSEcCtD
Isoprenaline—Vision blurred—Methotrexate—ankylosing spondylitis	0.000195	0.00764	CcSEcCtD
Isoprenaline—Vertigo—Methotrexate—ankylosing spondylitis	0.000186	0.00728	CcSEcCtD
Isoprenaline—Dizziness—Prednisolone—ankylosing spondylitis	0.000184	0.0072	CcSEcCtD
Isoprenaline—Asthenia—Triamcinolone—ankylosing spondylitis	0.000183	0.00719	CcSEcCtD
Isoprenaline—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000183	0.00717	CcSEcCtD
Isoprenaline—Insomnia—Prednisone—ankylosing spondylitis	0.000183	0.00716	CcSEcCtD
Isoprenaline—Convulsion—Methotrexate—ankylosing spondylitis	0.000179	0.00702	CcSEcCtD
Isoprenaline—Headache—Prednisolone—ankylosing spondylitis	0.000174	0.00682	CcSEcCtD
Isoprenaline—Dizziness—Triamcinolone—ankylosing spondylitis	0.000169	0.00662	CcSEcCtD
Isoprenaline—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000169	0.00661	CcSEcCtD
Isoprenaline—Asthenia—Dexamethasone—ankylosing spondylitis	0.000166	0.00652	CcSEcCtD
Isoprenaline—Asthenia—Betamethasone—ankylosing spondylitis	0.000166	0.00652	CcSEcCtD
Isoprenaline—Nausea—Prednisolone—ankylosing spondylitis	0.000165	0.00647	CcSEcCtD
Isoprenaline—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000163	0.0064	CcSEcCtD
Isoprenaline—Headache—Triamcinolone—ankylosing spondylitis	0.00016	0.00628	CcSEcCtD
Isoprenaline—Headache—Methylprednisolone—ankylosing spondylitis	0.00016	0.00626	CcSEcCtD
Isoprenaline—Hypotension—Methotrexate—ankylosing spondylitis	0.000158	0.00618	CcSEcCtD
Isoprenaline—Dizziness—Betamethasone—ankylosing spondylitis	0.000153	0.00601	CcSEcCtD
Isoprenaline—Dizziness—Dexamethasone—ankylosing spondylitis	0.000153	0.00601	CcSEcCtD
Isoprenaline—Insomnia—Methotrexate—ankylosing spondylitis	0.000153	0.00598	CcSEcCtD
Isoprenaline—Nausea—Triamcinolone—ankylosing spondylitis	0.000152	0.00595	CcSEcCtD
Isoprenaline—Nausea—Methylprednisolone—ankylosing spondylitis	0.000151	0.00594	CcSEcCtD
Isoprenaline—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00015	0.0059	CcSEcCtD
Isoprenaline—Headache—Dexamethasone—ankylosing spondylitis	0.000145	0.00569	CcSEcCtD
Isoprenaline—Headache—Betamethasone—ankylosing spondylitis	0.000145	0.00569	CcSEcCtD
Isoprenaline—Asthenia—Prednisone—ankylosing spondylitis	0.000145	0.00568	CcSEcCtD
Isoprenaline—Nausea—Dexamethasone—ankylosing spondylitis	0.000138	0.0054	CcSEcCtD
Isoprenaline—Nausea—Betamethasone—ankylosing spondylitis	0.000138	0.0054	CcSEcCtD
Isoprenaline—Dizziness—Prednisone—ankylosing spondylitis	0.000133	0.00523	CcSEcCtD
Isoprenaline—Headache—Prednisone—ankylosing spondylitis	0.000126	0.00496	CcSEcCtD
Isoprenaline—Asthenia—Methotrexate—ankylosing spondylitis	0.000121	0.00475	CcSEcCtD
Isoprenaline—Nausea—Prednisone—ankylosing spondylitis	0.00012	0.0047	CcSEcCtD
Isoprenaline—Dizziness—Methotrexate—ankylosing spondylitis	0.000112	0.00437	CcSEcCtD
Isoprenaline—Headache—Methotrexate—ankylosing spondylitis	0.000106	0.00414	CcSEcCtD
Isoprenaline—Nausea—Methotrexate—ankylosing spondylitis	0.0001	0.00393	CcSEcCtD
